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ABSTRACT Malignant hyperthermia (MH) results from a defect of calcium release control in skeletal muscle that is often
caused by point mutations in the ryanodine receptor gene (RYR1). In malignant hyperthermia-susceptible (MHS) muscle,
calcium release responds more sensitively to drugs such as halothane and caffeine. In addition, experiments on the porcine
homolog of malignant hyperthermia (mutation Arg615Cys in RYR1) indicated a higher sensitivity to membrane depolarization.
Here, we investigated depolarization-dependent calcium release under voltage clamp conditions in human MHS muscle.
Segments of muscle fibers dissected from biopsies of the vastus lateralis muscle of MHN (malignant hyperthermia negative)
and MHS subjects were voltage-clamped in a double vaseline gap system. Free calcium was determined with the fluorescent
indicator fura-2 and converted to an estimate of the rate of SR calcium release. Both MHN and MHS fibers showed an initial
peak of the release rate, a subsequent decline, and rapid turn-off after repolarization. Neither the kinetics nor the voltage
dependence of calcium release showed significant deviations from controls, but the average maximal peak rate of release was
about threefold larger in MHS fibers.
INTRODUCTION
Force activation in skeletal muscle fibers involves the rapid
release of calcium ions from the sarcoplasmic reticulum
(SR). This process is under direct control of the fiber
membrane potential. The membrane potential is sensed by
dihydropyridine receptors (DHP receptors) in the transverse
tubular system that transmit information to the calcium
release channels (ryanodine receptors) in the membrane of
the terminal cisternae of the SR and cause them to open (for
references see Melzer et al., 1995). Calcium release mea-
sured under voltage clamp conditions in isolated skeletal
muscle fibers appears to be positively and negatively mod-
ulated by calcium (Schneider and Simon, 1988; Jacque-
mond et al., 1991; Csernoch et al., 1993; Chandler et al.,
1995).
In the human skeletal muscle disorder malignant hyper-
thermia (MH), calcium release can be stimulated by clinical
doses of anesthetics and depolarizing muscle relaxants com-
monly used in general anesthesia (Gronert, 1994; MacLen-
nan and Phillips, 1992; Mickelson and Louis, 1996). Pre-
disposed persons are at high risk to develop a condition of
strongly increased muscle metabolism paired with muscle
rigidity and massive hyperthermia during general anesthe-
sia. If untreated, this condition is likely to be lethal. Stan-
dardized diagnostic tests have been developed in North
America, Europe, and Japan to identify the susceptibility to
malignant hyperthermia by measuring muscle force during
application of triggering agents (Britt, 1989; European Ma-
lignant Hyperpyrexia Group, 1984; Kawana et al., 1992). In
the European in vitro contracture test (IVCT), muscle bun-
dles obtained from a skeletal muscle biopsy are subjected to
increasing concentrations of caffeine and halothane. A sig-
nificantly lowered threshold for the initiation of a contrac-
ture by both substances signals that the individual is malig-
nant hyperthermia-susceptible (MHS).
Susceptibility to MH has been linked to several point
mutations in the gene of the predominant skeletal muscle
ryanodine receptor RYR1 (for a summary see Manning et
al., 1998). Transfection of cDNA encoding mutant channels
into muscle and nonmuscle cells led to expression of chan-
nels with higher caffeine and halothane sensitivity (Otsu et
al., 1994; Tong et al., 1997; Censier et al., 1998). In a
number of affected families, however, no linkage to the
ryanodine receptor gene has been found (Deufel et al.,
1992). One MH causing mutation in the 1-subunit of the
DHP receptor, the putative voltage sensor for calcium re-
lease, has been published (Monnier et al., 1997). As has
been the case in other channel diseases (Lehmann-Horn and
Ru¨del, 1996), naturally occurring mutations of the calcium
release channel may provide important clues to molecular
determinants for functional regions. Activation by calcium
has been described to occur at lower concentrations for the
human ryanodine receptors carrying mutation Gly2434Arg
(Richter et al., 1997). Such altered calcium-dependent mod-
ulation (inactivation or activation) of the ryanodine receptor
in MHS fibers might cause dynamic changes of the release
rate measured during step depolarization in the absence of
triggering agents.
One of the human RYR1 point mutations (Arg614Cys) is
also found at a homologous location (Arg615Cys) in the
porcine ryanodine receptor (Fujii et al., 1991) and causes a
recessively inherited oversensitivity to halothane and stress
(porcine stress syndrome). In porcine MH, a reduced sen-
sitivity to inactivation by a low-affinity calcium/magnesium
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binding site of the ryanodine receptor has been reported
(Laver et al., 1997). Work by Gallant and co-workers dem-
onstrated a lowered concentration threshold for potassium-
induced contractures in muscle from pigs carrying the mu-
tation (Gallant and Lentz, 1992; Gallant and Jordan, 1996).
The same group also showed a lowered voltage threshold
for contraction in porcine myotubes (Gallant and Jordan,
1996). Voltage clamp experiments on myotubes from pigs
homozygous for the Arg615Cys mutation showed activation
of calcium release at lower voltages (Dietze et al., 1997)
indicating altered voltage control caused by the mutation.
The present investigation is the first to study calcium
transients in isolated single muscle fibers of human MHS
individuals under voltage clamp conditions. It was carried
out to identify possible alterations in the voltage depen-
dence or time course of calcium release in this preparation.
METHODS
General procedure
Biopsies were obtained from the musculus vastus lateralis and used for MH
diagnosis in the in vitro contracture test according to the European proto-
col. The use of this material is in agreement with the Helsinki convention
and has been approved by the Ethics Commission of the University of Ulm.
The response of bundles of fiber segments to increasing concentrations of
caffeine and halothane served to classify subjects as normal (MHN),
malignant hyperthermia equivocal (MHE), or malignant hyperthermia sus-
ceptible (MHS) as described by the European Malignant Hyperpyrexia
Group (1984). Only MHN (controls) and MHS material were used for
single fiber experiments. Segments of isolated muscle fibers were dissected
from a bundle of the biopsy and voltage-clamped in a double vaseline gap
system while intracellular calcium changes were recorded with the fluo-
rescent indicator fura-2 (Fig. 1).
Because of the large amount of connective tissue and high fragility of
the fibers, the yield was low relative to comparable experiments on frog
fibers. Of a total of 108 experiments on human muscle fibers, 20 experi-
ments (18 biopsies) could be used to determine the voltage dependence of
calcium release. Of these, 11 experiments were on fibers of subjects
diagnosed MHS (9 biopsies).
Solutions
The following solutions were used for the experiments (concentrations in
mM):
Storing and transfer of the biopsies: NaCl (145), KCl (5), CaCl2 (2.5),
MgSO4 (1), HEPES (10), glucose (10), adjusted to pH 7.4 with NaOH.
Dissection of fiber bundles: NaCl (118), KCl (3.4), CaCl2 (2.5), MgSO4
(0.8), KH2PO4 (1.2), NaHCO3 (25), glucose (adjusted to 290 mosmol/l),
saturated with O2 (95%) and CO2 (5%).
Dissection of fiber segments: K2SO4 (95), HEPES (10), MgCl2 (10),
CaCl2 (0.4), adjusted to pH 7.4 with NaOH, osmolarity adjusted to 300
mosmol/l with sucrose.
External experimental solution: CH3SO3H (140), CaCl2 (2), MgCl2 (2),
HEPES (5), TTX (107 g/ml), adjusted to pH 7.4 with TEA-OH.
Internal (endpool) solution: glutamic acid (130), EGTA (0.1), HEPES
(10), CaCl2 (0,009), MgATP (5), (Na2-) creatine phosphate (5), glucose
(5), (K5-)fura-2 (0.2), adjusted to pH 7.2 with CsOH.
Voltage clamping
Voltage clamping of cut fibers was carried out in a double vaseline gap
system similar to the ones described in previous publications (Kovacs et
al., 1983; Feldmeyer et al., 1990). Fibers were mounted in a recording
chamber, which was constructed on a rectangular glass coverslip. The
solution volume in each of the three pools (two endpools  internal, one
middle pool  external) was 250 l. The voltage clamp electronics were
connected to the solution pools of the chamber via silver-silver chloride
electrodes bathed in 3 M KCl and via agar bridges (1.5%) equilibrated with
the respective pool solutions (excluding glucose, ATP, creatine phosphate,
and fura-2). For visual inspection and optical recording the chamber was
mounted on an inverted fluorescence microscope (Axiovert 135 TV,
Zeiss). Experiments were carried out at room temperature.
Calcium recording
Fibers were loaded from the cut ends with an artificial internal solution (see
above) containing 0.2 mM of fura-2. While loading the fiber, the resting
fluorescence at 500 nm was recorded during alternate excitation at 380 and
360 nm. Background fluorescence before fiber loading was subtracted.
When a sufficiently high concentration of internal indicator was reached,
calcium release was stimulated by depolarizing voltage steps. The fluores-
cence decrease at 380 nm excitation was recorded and divided by the
FIGURE 1 Experimental procedure. Muscle biopsies were split into
small bundles and used primarily for IVCT diagnostics. A small portion of
the material was used for dissecting single fiber segments for recording
calcium-dependent fluorescence changes under voltage-clamp conditions.
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resting fluorescence at 360 nm excitation (isosbestic wavelength). The
fluorescence ratio signal was converted to free calcium concentration using
Eq. 1, which corrected for kinetic delays due to noninstantaneous calcium
binding to the indicator dye (Klein et al., 1988).
Ca2
dR/dt koffR Rmin	
konRmax R	
(1)
The parameters kon  1.44 
 108 M1 s1, koff  26 s1, Rmax  7.05,
Rmin  1.93 were obtained from calibration experiments on frog muscle
fibers (Struk et al., 1998) using the same setup.
Initial experiments were done with 1 mM internal free magnesium,
which is commonly used for experiments in frog fibers. Under these
conditions calcium transients were small and rose slowly upon depolariza-
tion. Mammalian fibers have been reported to contain lower concentrations
of free magnesium (MacDermott, 1990; Westerblad and Allen, 1992).
Reducing magnesium to obtain a free concentration of 0.5 mM improved
the signal rise time and size and these conditions were therefore applied
throughout.
RESULTS
In vitro contracture test
Fig. 2 shows the averaged results of the in vitro contracture
test for the biopsies from which fibers were successfully
used in our voltage clamp experiments. The result of the
test, i.e., the force response to varying concentrations of
caffeine and halothane, was used to distinguish the MHS
group from controls (MHN). Clearly, MHS fiber bundles
exhibited contracture force in a concentration range of halo-
thane (Fig. 2 B) where MHN fibers showed no response. In
MHS fibers, force developed at markedly lower concentra-
tions of caffeine (Fig. 2 A).
Calcium release in voltage clamp experiments
Short segments of single muscle fibers were set up in a
three-pool chamber as described in Methods. The cut ends
were exposed to an artificial internal solution containing the
fluorescent indicator dye fura-2. Before the dye reached the
middle section of the fiber by diffusion, the membrane was
clamped to a holding potential of 90 mV. Loading of the
fibers as judged by the increase of resting fluorescence at
360 nm excitation was generally achieved 1.5–2 times faster
than in frog fibers mounted in the same way in the same
chamber and equilibrated with 100 M fura-2. When load-
ing approached a steady state, step depolarizations were
applied to release calcium from the sarcoplasmic reticulum.
The response to a 50-ms lasting depolarization (Fig. 3 A) is
shown in Fig. 3 B. It shows the ratio R  F380/F360. The
drop in the ratio value corresponds to a change in fractional
calcium occupancy of the indicator dye from initially 46%
to 75% at the end of the pulse. This is considerably smaller
for this strength of depolarization than typically found in
our experiments on frog fibers filled with comparable in-
ternal solutions. As in all other experiments, occupancy
remained well below 100%, which justifies the use of the
high-affinity indicator fura-2.
The result of converting the ratio signal to the transient of
free myoplasmic calcium and correction for the noninstan-
taneous binding of calcium to the indicator by means of Eq.
1 is shown in Fig. 3 C. It should be noted that the relatively
high concentration of the indicator dye certainly influences
the time course of the free calcium transient, in particular
the slow decay at the end of the pulse is partly due to
buffering by the dye.
To get an estimate of the time course of calcium release
from the sarcoplasmic reticulum we applied the method first
described by Baylor et al. (1983). It uses reasonable esti-
mates of the binding site concentrations in the fiber and
literature values of rate constants for the main calcium
binding sites determined in biochemical studies. With these
data the time course of occupancy of each calcium com-
partment is calculated using the measured calcium transient.
The sum of free and bound (or sequestered) calcium is the
total amount of release and the time derivative of the total
release is the rate of release from the SR. In the calculation
we included fast calcium-specific sites on troponin C (T-
sites), slow calcium-magnesium sites on troponin C (P-
sites), EGTA, fura-2, and a contribution of the SR calcium
pump (see Fig. 3 caption for references). Heizmann (1984)
reported that m. vastus lateralis contains no parvalbumin.
Therefore, parvalbumin was omitted from the calculation.
FIGURE 2 Results of the in vitro
contracture test (IVCT). (A) Average
cumulative force response of small
biopsied muscle bundles to varying
concentrations of caffeine. (B) Force
response as a function of halothane
concentration. Open symbols: MHN
(nine biopsies); closed symbols:
MHS (nine biopsies). Bundles had a
diameter of 3 mm and a length of
20 to 25 mm.
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When parvalbumin was included, the release rate estimates
showed a constant non-zero level after the end of the pulse
(not shown) while lack of parvalbumin was compatible with
complete turn-off of release at repolarization. The result of
the calculation is shown in Fig. 3 D.
The time course of the rate of release derived in this way
exhibits the features previously described for amphibian
(e.g., Melzer et al., 1984, 1987) and mammalian muscle
(Garcia and Schneider, 1993; Delbono et al., 1995; Shi-
rokova et al., 1996; Szentesi et al., 1997), i.e., an initial peak
followed by a decay to a considerably lower value and a
rapid turn-off after repolarization to the holding potential of
90 mV. Due to the sensitivity of the preparation, pulses
had to be confined to relatively short durations (generally 50
ms). Therefore, we could not apply procedures to discrim-
inate between inactivation of release and depletion of the
SR to estimate SR permeability (Jacquemond et al., 1991),
because they require long depolarizations.
Voltage dependence of calcium release
Free calcium was calculated according to Eq. 1. There is
relatively close agreement among different groups on the
value of the parameter koff. Our own experiments on frog
muscle fibers gave a value of 26 s1, which equals the value
determined in rat fibers by Garcia and Schneider (1993). We
used this value in Eq. 1. The estimates of kon show a larger
variance. Estimating the release rate requires the solution of
a set of nonlinear differential equations. The time course of
the release rate estimate might change depending on the
scale of the calcium transient used for the calculation. In
Fig. 4 we compare calculated release rates for two different
choices of kon leading to a difference in amplitude of the
calcium transient by a factor of 5. As can be seen, the
general shape of the release rate waveforms was relatively
invariant to this amplitude change. Furthermore, the uncer-
tainties in scaling should be irrelevant for comparing MHN
and MHS fibers, which were both subjected to the same
calculation procedure. In the remaining part of this paper we
used the fura-2 kinetic parameters introduced in Fig. 3.
Fig. 5 compares calculated release rates for depolarizing
pulses of different amplitude both in a control muscle fiber
(A) and in a fiber of a patient diagnosed MHS (B). In both
cases the release rate exhibits the same general phasic time
course (30 mV). For rat fibers it has been reported that
the ratio of peak to steady level is approximately constant at
different potentials (Shirokova et al., 1996). Even though at
50 ms the final level was not attained in all cases, it became
apparent that generally the peak increased in relation to the
level that the release rate decayed to during the pulse.
At the bottom of the figure the peak rates of release are
plotted versus pulse voltage and the relation is fitted by a
Boltzmann distribution. The parameters describing the volt-
age dependence differ only slightly. Half-maximal activa-
tion is attained at 14 mV (control) and 9 mV (MHS)
respectively, and the steepness parameter k is 7.8 and 7.1
mV, respectively. The amplitude is more than three times
larger in the MHS fiber.
Fig. 6 shows the average results regarding the voltage
dependence of all MHN and MHS fibers. Each set of data
from individual fibers was fitted separately by a Boltzmann
equation. The results of the individual fits are summarized
in Table 1 (MHN) and Table 2 (MHS). The plots in Fig. 6
show the data normalized to the maximal value obtained by
FIGURE 3 Estimation of the calcium release rate from fura-2 fluores-
cence transients measured during step depolarization. (A) Membrane de-
polarization (schematic) from 90 mV to 0 mV. (B) Fluorescence at 380
nm excitation divided by the resting fluorescence at 360 nm. (C) Free
calcium calculated from (B) according to Eq. 1. (D) Rate of release, i.e., the
time derivative of total calcium, calculated by solving the dynamic model
equations of Brum et al. (1988) using the following set of parameters. On-
and off-rate constants and total concentration of troponin C calcium-
specific binding sites (T-sites; values according to model 1 of Pape et al.,
1993): kon  57.5 M1 s1, koff  115 s1, [T]  240 M. On- and
off-rate constants for calcium and magnesium and total concentration of
parvalbumin-type binding sites (P-sites; values according to model 1 of
Pape et al., 1993): kon,Ca  125 M1 s1, koff,Ca  0.5 s1, kon,Mg 
0.033 M1 s1, koff,Mg  3 s1, [P]  240 M. On- and off-rate
constants for calcium and total concentration of EGTA (values according
to Pape et al., 1995): kon  2.5 M1 s1, koff  0.94 s1, [EGTA]  100
M. Sarcoplasmic reticulum pump (values according to Shirokova and
Rios, 1996): pump stoichiometry n  2, maximal pump rate M  1
Mms1, dissociation constant of individual pump site KD  1 M,
concentration of pump sites 50 M. Experiment 286.
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the fit and voltages displayed as deviations from the mean
voltage of half-maximal activation. This voltage and the
average steepness parameter k of the Boltzmann relation
were almost identical in the MHN and MHS population of
fibers (12.0 1.5 mV and 6.9 0.3 mV versus12.5
1.5 and 6.3  0.4 mV). A significant difference, however,
was found in the mean values of the absolute amplitudes of
the release rates: 2.1  0.8 (n  9) in normal fibers versus
5.6  1.0 (n  11) in MHS fibers; i.e., on average release
flux was 2.7-fold larger in MHS fibers. A similar result was
obtained when the raw fluorescence signals normalized to
resting fluorescence were fitted as a function of voltage (see
relative fluorescence change in Tables 1 and 2). In the same
way we analyzed the end values of the release rates (average
of the last 10 points during the stimulus interval). The
variances were considerably larger but the result was equiv-
alent. Maximum value, V0.5, and k of the Boltzmann fit were
0.71  0.26 M/ms, 9.0  10.0 mV, and 9.0  5.5 mV
(MHN) and 2.1  0.7 M/ms, 17.0  7.0 mV, and 6.0 
2.1 mV (MHS), respectively. Again, only the maximal
values were significantly different.
Inspecting the individual maximal release rates revealed
that all MHS fibers ranged between 2 and 11 M/ms while
about half the MHN fibers had considerably lower ampli-
tudes (below 1 M/ms). Fig. 7 shows that this amplitude
variation correlates with the age of the subjects. The smaller
amplitudes were exclusively found in fibers from subjects
older than 40.
Time course of calcium release
The examples chosen for Fig. 5 suggest a difference in the
time course of calcium release rates, i.e., a faster decay after
the peak in the MHS fiber. We tried to substantiate a
possible difference in time course by averaging all calcu-
lated release rates from different fibers for a depolarization
to 0 mV. The result is shown in Fig. 8. The bold line
presents the average (normalized to the peak) and the thin
lines indicate the standard error for each mean value. The
two normalized curves were not significantly different.
For a second comparison of the time course, the decay
phase of each individual rate of release record was fitted by
a single exponential plus a constant. This analysis was
FIGURE 4 Calculated release rates assum-
ing two different absolute scales of free cal-
cium. A set of experimental records for volt-
age pulses to 20, 10, 0, and 10 mV (50
ms) was used. Two different assumptions for
kon-fura were used in deriving free calcium
(Eq. 1) leading to a difference in absolute
scale by a factor of 5: (A) kon-fura  1.44 
108 M1 s1; (B) kon-fura  0.3  108
M1 s1. Experiment 304 (MHS fiber).
FIGURE 5 Voltage dependence of the rate of calcium release in an
MHN (control) and an MHS fiber. Step depolarizations of 50 ms duration
to voltages between 50 and 0 mV were applied. The figure shows the
superthreshold responses. Insets at the bottom of the figure: voltage de-
pendence of peak release rates and the parameters obtained from a least-
squares fit of a Boltzmann function to the data. (A) Experiment 251
(MHN); (B) experiment 309 (MHS)
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carried out for pulses to 10, 0, and 10 mV. The time
constants were 18 6 ms (n 4), 11 1 ms (n 7), 10
3 ms (n  4) for MHN, and 15  3 ms (n  10), 12  1
ms (n 10), 12 1 ms (n 6) for MHS, respectively. The
time constants of decay after the peak did not differ signif-
icantly at the three potentials. The same result was found
when comparing time course and decay time constants
separately for the age groups below and above 40 years.
Thus, an alteration in the time course of the calcium release
rate in MHS fibers could not be confirmed.
DISCUSSION
In the present study we investigated calcium release in
muscle fibers of malignant hyperthermia-susceptible human
FIGURE 6 Average normalized voltage
dependence of the peak rate of release. (A)
MHN (control); (B) MHS; (C) average max-
imal amplitude (obtained from Boltzmann
fits).
TABLE 1 Voltage dependence of fluorescence signal and calculated calcium release rate in control fibers
Fiber
Age
(years)
Relative fluorescence change (F/F) Peak rate of release
Maximum
V0.5
(mV)
k
(mV)
Maximum
(mM/s)
V0.5
(mV)
k
(mV)
124 34.2 0.416 13.4 6.1 4.5 10.2 6.4
133 34.4 0.496 13 4.3 6.8 8.0 5.7
243 43.8 0.039 11.1 8.4 0.17 14.6 6.6
251 33.4 0.360 14.6 8.2 2.9 11.3 8.02
256 39.2 0.230 7.1 8.8 2.0 7.1 7.38
263 56.9 0.044 24 4.7 0.32 24.2* 4.9*
274 40.4 0.030 7.0 13 0.15 19.5 8.13
286 33.6 0.180 14.6 7.2 1.63 9.9 7.07
312 48.1 0.094 9.5 9.6 0.4 15.7 6.1
Mean 40.4 0.210 12.7 7.8 2.1 12.0 6.9
S.E.M. 0.059 1.7 0.9 0.8 1.5 0.3
S.D. 8 0.177 5.1 2.7 2.3 4.2 0.9
n 9 9 9 9 9 8 8
p – 0.01 n.s. n.s. 0.01 n.s. n.s.
n, Number of experiments; p, WILCOXON significance level for comparison with mean values of the MHS ensemble (Tab 2); n.s., not significant.
*Bad fit, not included in average.
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subjects. We used microfluorimetry to record calcium sig-
nals stimulated with voltage clamp depolarizations from
isolated cut-open muscle fiber segments. The experiments
allowed assessment of both voltage dependence and time
course of calcium release in normal and MHS muscle fibers.
We confirmed the phasic time course of voltage-depen-
dent calcium release that has been shown in studies on frog
and rat fibers (Melzer et al., 1984, 1987; Garcia and Schnei-
der, 1993; Shirokova et al., 1996) and in one report on
human muscle (Delbono et al., 1995). In both normal and
MHS fibers the release rate reached a peak soon after
depolarization and declined rapidly thereafter. Release was
strongly reduced (probably completely turned off) almost
instantly after repolarization to the holding potential.
Compared to experiments on frog fibers carried out with
the same methods in the same setup the average peak
release rate amplitudes determined in human fibers were
smaller by a factor of 10. Extrapolating to the physiolog-
ical temperature of 37°C by using Q10 values between 3 and
4 determined for the peak release rate in rat fibers (Shi-
rokova et al., 1996) leads to scaling factors between 5.6 and
8.8 for the human fibers. Following the arguments of Shi-
rokova et al. (1996), remaining differences between frog
and human fibers in their release rates at the respective
physiological temperatures may be a result of the fact that
mammalian fibers have two release regions per sarcomere,
while frog fibers have only one. Furthermore, in the vastus
lateralis fibers the apparent lack of parvalbumin may require
less release to reach similar calcium levels. Another reason
for finding low release rates in our human fibers may be a
low loading state of the SR resulting from the biopsy
procedure: the fibers had to be cut during surgery and to be
maintained in the cut state for a much longer time before use
in the experiment than frog fibers.
Information on the voltage dependence of release in
human fibers has not been described yet. In our experi-
ments, the ratio of peak release to the value attained at the
end of the depolarizing pulse (50 ms) often increased with
increasing depolarization. In rat muscle, this ratio had been
reported to be independent of voltage in the range 60 to
10 mV, while frog fibers exhibited a maximum at 40
mV (Shirokova et al., 1996). Compared to rat fibers, the
human fibers may have had a higher contribution from
depletion at early times during large depolarization, possi-
bly due to a less efficient reuptake or insufficient luminal
buffering. Inasmuch as the mechanisms determining the
complex time course of the release rate are not yet satisfac-
torily understood, other reasons regarding the control mech-
TABLE 2 Voltage dependence of fluorescence signal and calculated calcium release rate in MHS fibers
Fiber
Age
(years)
Relative fluorescence change F/F Peak rate of release
Maximum
V0.5
(mV)
k
(mV)
Maximum
(mM/s)
V0.5
(mV)
k
(mV)
114* 37.0 0.473 18 5.1 6.9 13 7
168 21.5 0.457 6.5 4.5 4.4 6 {3.9}
224# 32.8 0.234 16.4 8.5 2.0 18 6.9
226# sic 0.355 15.0 6.9 3.0 22 5.8
240§ 51.9 0.434 9.4 8.8 4.6 8 8.1
241§ sic 0.686 25.4 5.1 11.4 15 5.9
272¶ 41.6 0.351 11.1 6.7 3.2 10 5.7
304 60.5 0.362 13.3 6.2 3.7 11 5.9
305 34.3 0.470 18.9 5.0 5.1 15.5 4.14
309* 41.1 0.541 16.8 5.94 11.4 8.8 6.8
310 56.5 0.435 19.8 3.84 6.03 12.9 4.4
Mean 42.0 0.436 15.5 6.1 5.6 12.5 6.3
S.E.M. 0.035 1.6 0.5 1.0 1.5 0.4
S.D. 11.9 0.116 5.3 1.6 3.2 4.9 1.1
n 11 11 11 11 11 10 9
*Mutation Gly2434Arg.
#Mutation Gly2434Arg; fibers from same patient.
§Fibers from same patient.
¶Mutation Arg614Cys.
Bad fit, not included in average.
FIGURE 7 Maximum release rate plotted as a function of age. Open
symbols: MHN (controls); filled symbols: MHS.
2408 Biophysical Journal Volume 75 November 1998
anism of the release channels are possible. For instance,
with larger depolarization more and more release channels
may be activated indirectly by calcium rather than directly
by voltage (see the dual control model of calcium release
presented by Shirokova et al., 1996). In contrast to our
experiments, those of Shirokova et al. (1996), who had
obtained a voltage-independent ratio, had been done with 8
mM EGTA in the internal solution, which reduces cross talk
between adjacent ryanodine receptors (Pape et al., 1995).
The release exhibited a sigmoidal dependence on voltage
that could be well described by a single Boltzmann relation.
The result was consistent with a gating mechanism that
displayed a dipole moment change equivalent to the dis-
placement of four elementary charges across the membrane
electrical field. Threshold activation was 30 mV, which
corresponds to experiments in rat fibers by Garcia and
Schneider (1993), whereas Shirokova et al. (1996) obtained
detectable calcium transients in rat fibers already at 60
mV.
The average peak release rate was markedly higher in the
MHS fibers, which could be the result of enhanced calcium-
dependent activation or reduced inactivation [for instance,
reduced steady-state inactivation by myoplasmic magne-
sium as proposed by Owen et al. (1997) and Laver et al.
(1997)]. A decrease in release activity with age as seen in
the control fibers has also been reported by Delbono et al.
(1995), yet to a considerably smaller extent. They attributed
their effect to a reduced density of voltage sensors. In the
MHS fibers the negative correlation of release with age was
absent. Possibly a higher contribution of secondary, i.e.,
calcium-induced, release could make overall release less
sensitive to a downregulation of voltage sensors. Significant
alterations in kinetics could not be identified in our exper-
iments. However, due to the relatively large variability of
the signals, small changes in the decline rate cannot be ruled
out.
A change in the voltage dependence of activation as
reported by Gallant and Lentz (1992), Gallant and Jordan
(1996), and Dietze et al. (1997) could not be found in our
human fibers. Both steepness and half-maximal voltage for
activation were the same. One reason for the difference
between human and porcine muscle could be the nature of
the mutation. In the studies on pig muscle, a genetically
homogeneous group including only preparations with the
Arg615Cys mutation, was studied. The common character-
istic of our MHS fibers was the positive result of the
diagnostic test, i.e., the higher sensitivity to caffeine and
halothane. However, the genetic basis of MH in humans is
heterogeneous. A higher sensitivity of the ryanodine recep-
tor to the voltage sensor input may be restricted to only
certain types of mutations (among them porcine
Arg615Cys). In our experiments only one fiber was from a
carrier of the Arg615Cys mutation; it showed no obvious
deviation from the control results. The dominating mutation
was Gly2434Arg (4 of 11 fibers, see Table 2). The best-fit
parameters of this subgroup, taken separately, were not
significantly different from those of the whole ensemble of
MHS fibers. For the remaining fibers a causative mutation
has not yet been identified.
In summary, we compared calcium release characteristics
under voltage clamp conditions of muscle fiber segments
isolated from normal human subjects with those of patients
diagnosed as malignant hyperthermia-susceptible. We
found no significant difference in voltage dependence nor in
time course of calcium release between the two populations
of fibers. Instead, the average release rate at maximal acti-
vation was markedly increased in MHS fibers.
We thank the surgery staff of the Rehabilitationskrankenhaus Ulm for
carrying out the diagnostic biopsies, Dr. Ch. Baur, U. Mohr, and E. Schoch
for providing us with results of the in vitro-contracture test, and Dr. L.
Schleithoff and A. Brandt for information on the genotyping of MHS
patients. We are grateful to Dr. G. Szu¨cs for help and stimulating sugges-
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and B. Dietze for valuable discussions. This work was supported by the
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